- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insight 355 results
COVID-19 Vaccine Updates
April 16, 2021
HHS Office for Civil Rights Publishes Legal Guidance Around Access to COVID-19 Vaccines for People with Disabilities and Older Adults
COVID-19 Vaccine Updates
April 16, 2021
CDC and FDA Release Joint Statement on Johnson & Johnson COVID-19 Vaccine
COVID-19 Vaccine Updates
April 15, 2021
Pfizer and BioNTech Ask FDA to Approve COVID-19 Vaccine for Children Ages 12 to 15
COVID-19 Vaccine Updates
April 9, 2021
CDC Awards $3 Billion to Expand COVID-19 Vaccine Programs
COVID-19 Vaccine Updates
April 9, 2021
HHS Launches COVID-19 Community Corps
COVID-19 Vaccine Updates
April 7, 2021
CDC Announces Nearly 80 Percent of Teachers, School Staff, and Childcare Workers Received a COVID-19 Vaccine Dose
COVID-19 Vaccine Updates
April 6, 2021
White House Provides Update on Vaccination Program
Newsletter
April 5, 2021
Health Headlines - April 5, 2021
COVID-19 Vaccine Updates
April 1, 2021
FDA Revises Emergency Use Authorization for Moderna COVID-19 Vaccine
Client Alert
COVID-19 Vaccine Updates
March 30, 2021
UNO Pizzeria & Grill Launches Vaccine Concierge Service for Employees
COVID-19 Vaccine Updates
March 29, 2021
White House COVID-19 Response Team Addresses Possible Surge in Coronavirus Cases
COVID-19 Vaccine Updates
March 29, 2021
CDC Publishes Study on Effectiveness of COVID-19 Vaccines
COVID-19 Vaccine Updates
March 26, 2021
Walgreens Announces First Corporate COVID-19 Vaccine Clinics
Client Alert
March 26, 2021
Medicare Coverage Breakthrough Delayed
COVID-19 Vaccine Updates
March 25, 2021
FDA Authorizes Catalent Plant to Help Manufacture Johnson & Johnson COVID-19 Vaccine
COVID-19 Vaccine Updates
March 25, 2021
CDC Publishes Report on Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Skilled Nursing Facilities
COVID-19 Vaccine Updates
March 25, 2021
March 24 Vaccine Rollout Updates from the White House COVID-19 Response Team
COVID-19 Vaccine Updates
March 22, 2021
King & Spalding Attorney Ahsin Azim Comments on COVID-19 Vaccine Regulatory Environment
COVID-19 Vaccine Updates
March 22, 2021
EU Officials Weigh Tighter Restrictions on COVID-19 Vaccine Exports to UK
COVID-19 Vaccine Updates
March 17, 2021
White House COVID-19 Response Team Addresses Vaccine Passports
COVID-19 Vaccine Updates
March 17, 2021
Moderna Starts COVID-19 Vaccine Trial for Infants and Young Children
COVID-19 Vaccine Updates
March 16, 2021
CDC Encourages Large Employers to Consider Workplace Vaccination Programs
COVID-19 Vaccine Updates
March 16, 2021
CDC Publishes Second-Dose Completion and Interval Data for the First Two Months of Vaccine Administration
COVID-19 Vaccine Updates
March 16, 2021
CDC Launches Smartphone App to Report COVID-19 Vaccine Side Effects
COVID-19 Vaccine Updates
March 15, 2021
Biden Administration Increases Medicare’s Reimbursement Rates for COVID-19 Vaccine
Client Alert
March 15, 2021
The Establishment of the White House Gender Policy Council and Its Implications for FDA Initiatives and Priorities
Newsletter
March 15, 2021
Health Headlines – March 15, 2021
COVID-19 Vaccine Updates
March 15, 2021
HHS Amends PREP Act to Expand the List of Authorized Vaccinators
COVID-19 Vaccine Updates
March 12, 2021
White House Announces All Adults Will be Eligible for Vaccination by May 1
Article
March 11, 2021
Biden Administration - What's Ahead for the Life Sciences Industry?
Article · Source: The New York Law Journal
March 11, 2021
The Importance of Epidemiology To Contextualize Safety Signals Associated With Women's Health Products
COVID-19 Vaccine Updates
March 10, 2021
Biden Administration Plans to Purchase 100 Million Additional Johnson & Johnson Vaccine Doses
COVID-19 Vaccine Updates
March 9, 2021
CDC Issues Guideline on How Fully Vaccinated People Can Visit Safely with Others
Newsletter
March 8, 2021
Health Headlines – March 8, 2021
COVID-19 Vaccine Updates
March 2, 2021
White House Invokes the Defense Production Act to Accelerate Johnson & Johnson Vaccine Production
COVID-19 Vaccine Updates
March 1, 2021
White House Highlights Private Company Efforts to Defeat COVID-19
COVID-19 Vaccine Updates
March 1, 2021
Johnson & Johnson to Distribute 20 Million Vaccine Doses Throughout March
COVID-19 Vaccine Updates
February 27, 2021
FDA Issues Emergency Use Authorization for Janssen COVID-19 Vaccine
COVID-19 Vaccine Updates
February 26, 2021
Private-Public Partnership in Charlotte Publishes Strategies for Safe, Fast, and Equitable Mass Vaccination Events
COVID-19 Vaccine Updates
February 25, 2021
FDA Approves Storage of Pfizer-BioNTech COVID-19 Vaccine at Higher Temperatures
COVID-19 Vaccine Updates
February 23, 2021
Increased Reliance on the DPA to Fight COVID-19 Has Major Impact on Supplies of Other Drugs and Therapies
COVID-19 Vaccine Updates
February 22, 2021
FDA Issues Additional Guidance for Medical Product Developers Addressing Virus Variants
Newsletter
February 22, 2021
Health Headlines – February 22, 2021
COVID-19 Vaccine Updates
February 22, 2021
CDC Publishes Resources from the National Forum on COVID-19 Vaccine
COVID-19 Vaccine Updates
February 22, 2021
February 22 Vaccine Rollout Updates from the White House COVID-19 Response Team
COVID-19 Vaccine Updates
February 19, 2021
White House COVID-19 Response Team Addresses Impact of Severe Weather on Vaccine Rollout
COVID-19 Vaccine Updates
February 19, 2021
CDC Publishes Safety Monitoring Data for the First Month of Vaccination Administration
COVID-19 Vaccine Updates
February 17, 2021
White House COVID-19 Response Team Addresses Johnson & Johnson Vaccine Rollout Plans
COVID-19 Vaccine Updates
February 17, 2021
CDC Publishes Reports on COVID-19 Variants
COVID-19 Vaccine Updates
February 17, 2021
February 16 Vaccine Rollout Updates from the White House
COVID-19 Vaccine Updates
February 16, 2021
Extreme Winter Weather Disrupts Vaccine Distribution
COVID-19 Vaccine Updates
February 16, 2021
U.S. Government and Private Companies Take Steps to Thwart Bad Actors in Vaccine Rollout
Client Alert
February 12, 2021
GSK v. Teva and Induced Infringement by AB-Rated Generics: Where are we now?
COVID-19 Vaccine Updates
February 10, 2021
White House Announces Members of COVID-19 Health Equity Task Force & Plans to Build More Mass Vaccination Centers
COVID-19 Vaccine Updates
February 10, 2021
DHS and FEMA Make Statements Regarding Efforts to Ensure Equity in Vaccine Distribution
COVID-19 Vaccine Updates
February 10, 2021
CDC Publishes Demographic Data for the First Month of the Vaccine Rollout
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
COVID-19 Vaccine Updates
February 9, 2021
February 8 Vaccine Rollout Updates from the White House COVID-19 Response Team
Newsletter
February 8, 2021
Health Headlines – February 8, 2021
Client Alert
February 5, 2021
FDA Appoints Renowned Cybersecurity Researcher to Head Agency's Medical Device Cybersecurity Efforts
Client Alert
February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023
Client Alert
February 2, 2021
USDA Issues Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans
Newsletter
January 25, 2021
Health Headlines – January 25, 2021
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Technology Industry
Feature
January 21, 2021
General Counsel Internal Investigations Decision Tree for the Financial Services Industry
Newsletter
January 19, 2021
Health Headlines – January 19, 2021
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
Feature
January 15, 2021
General Counsel’s Decision Tree
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Food and Beverage Industry
Article · Source: Law360
January 5, 2021
A Legislative Solution For Medicare Claims Settlement Delays
Client Alert
January 4, 2021
FDA Establishes – And HHS Immediately Withdraws – New OTC Drug User Fee Rates
Newsletter
January 4, 2021
Health Headlines – January 4, 2021
Client Alert
December 31, 2020
Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers
Newsletter
December 28, 2020
Health Headlines – December 28, 2020
Newsletter
December 21, 2020
Health Headlines – December 21, 2020
Client Alert
December 17, 2020
CMS Proposes New DMEPOS Coverage Policies and Payment Rates, and Seeks to Codify HCPCS Application, Benefit Category and Payment Determination Processes
Client Alert
December 14, 2020
HHS Finalizes 340B Administrative Dispute Resolution Process
Newsletter
December 14, 2020
Health Headlines – December 14, 2020
Client Alert
December 11, 2020
Department of Justice Vows Vigorous Enforcement of Clinical Trial Fraud
Newsletter
December 7, 2020
Health Headlines – December 7, 2020
Thought Leadership
December 2, 2020
Key Takeaways From the 13th Annual King & Spalding Medical Device Summit
Client Alert
November 30, 2020
Europe – Towards a More Harmonized Market for CBD?
Newsletter
November 30, 2020
Health Headlines – November 30, 2020
Client Alert
November 25, 2020
HHS Finalizes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
Client Alert
November 24, 2020
Are Pharma Speaker Programs Facing an Existential Crisis?
Newsletter
November 23, 2020
Health Headlines – November 23, 2020
Client Alert
November 23, 2020
He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform
Article · Source: Food and Drug Law Institute
November 20, 2020
That Will Leave a Mark: FDA’s Shifting Approach to Regulating the Coronavirus Testing Market Creates Confusion, Opportunities, and Enforcement Risk
Article · Source: For the Defense
November 17, 2020
An Evolving Landscape: The FDA's Regulation of Cannabis
Newsletter
November 16, 2020
Health Headlines – November 16, 2020
Newsletter
November 9, 2020
Health Headlines – November 9, 2020
Newsletter
November 2, 2020
Health Headlines – November 2, 2020
Client Alert
October 26, 2020
France - Trial Period for Medical Use of Cannabis-Based Products
Article · Source: Law360
October 26, 2020
Avoiding Shareholder Class Actions After FDA Drug Denials